Codexis

Codexis Net Tangible Assets

The Net Tangible Assets of Codexis (CDXS) as of Sep 27, 2026 is 48.07 M USD. In the previous year, Net Tangible Assets was 64.46 M USD — a change of -25.44% (lower).

Net Tangible Assets

48.07 MUSD

YoY

-25.44%

Last updated:

Net Tangible Assets of Codexis is 2026 48.07 M USD. Net Tangible Assets of Codexis was 2025 64.46 M USD. It decreases by -25.44% lower compared to the previous year.

The Codexis Net Tangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Tangible Assets
Date
Net Tangible Assets
Jan 1, 2018
53.07 M USD
Jan 1, 2019
102.28 M USD
Jan 1, 2020
166.86 M USD
Jan 1, 2021
161.15 M USD
Jan 1, 2022
141.56 M USD
Jan 1, 2023
84.15 M USD
Jan 1, 2024
64.46 M USD
Jan 1, 2025
48.07 M USD
The Codexis Net Tangible Assets history
YEARNet Tangible AssetsYoY
48.07 MUSD-25.44%
64.46 MUSD-23.40%
84.15 MUSD-40.55%
141.56 MUSD-12.16%
161.15 MUSD-3.42%
166.86 MUSD+63.15%
102.28 MUSD+92.74%
53.07 MUSD+149.06%
21.31 MUSD+34.35%
15.86 MUSD-5.82%
16.84 MUSD-0.19%
16.87 MUSD—
Access this data via the Eulerpool API

Codexis Stock analysis

What does Codexis do? Codexis Inc. is an American biotechnology company that specializes in developing innovative biological solutions for a variety of industries. The company was founded in 2002 and is headquartered in Redwood City, California. Business Model: Codexis is service-oriented and provides customized enzyme solutions for companies looking to improve their products through sustainable processes. The company has developed a unique platform called Rational Protein Engineering, which allows for the development of specific enzymes for various industries. Customers benefit from enzyme optimization expertise and know-how. Divisions: Codexis operates in the fields of life sciences, materials science, agrochemicals, and biofuels. 1. Life Sciences: Codexis specializes in the production of enzymes and biocatalysts for the pharmaceutical industry in the life sciences division. The goal is to provide a faster and more efficient manufacturing process for pharmaceutical active ingredients. The company has successfully developed active ingredients for antibodies, lipids, uric acid, and antivirals. 2. Materials Science: In the materials science division, Codexis specializes in the production of enzymes for materials such as dyes, polymers, and cosmetic products. Codexis ensures that these products are efficiently manufactured without the use of environmentally harmful chemicals. 3. Agrochemicals: Codexis offers customized enzyme solutions to agrochemical manufacturers that reduce the use of chemicals and benefit the environment. These enzymes help in the production of pesticides and other agrochemicals. 4. Biofuels: In the biofuels division, Codexis specializes in the production of enzymes for processing corn, harvested plants, or waste products. These enzymes help enable cost-effective biofuel production. Products: Codexis has developed a wide range of products tailored to the needs of various industries. Some of the products recently introduced to the market by Codexis include: 1. CodeEvolver: CodeEvolver is a platform that allows biotechnology companies to quickly create customized enzyme solutions for their specific needs. The process is fully automated and results in a significant reduction in development time and costs. 2. Codex® screening panels: Codexis offers various screening panels that allow customers to quickly and efficiently select the enzymes best suited for their purposes. The panels are suitable for industries including pharmaceuticals, chemicals, and plant protection. 3. Codex® enzymes: Codexis offers a wide range of enzymes specifically designed for different industry needs. This includes enzymes for the production of biofuels, pesticides, cosmetic products, and pharmaceuticals. Overall, Codexis Inc. has demonstrated its ability to deepen the understanding of biocatalysts and introduce innovative biological processes in a variety of industries through its unique Rational Protein Engineering platform. Codexis is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Codexis stock

Net Tangible Assets of Codexis is 48.07 M USD in 2026.

Net Tangible Assets of Codexis changed from 64.46 M USD to 48.07 M USD, representing a -25.44% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Tangible Assets Codexis since 2006 – with annual values, charts, and detailed analysis.

Net tangible assets equal total assets minus intangible assets, goodwill, and liabilities. They represent the physical asset backing of a company.

Net Tangible Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Tangible Assets's Codexis historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Codexis

All Key Metrics — Codexis